[First case of COVID-19 treated with tocilizumab in Iceland]

Laeknabladid. 2020;106(5):247-250. doi: 10.17992/lbl.2020.05.581.
[Article in Icelandic]

Abstract

A gentleman in his early fifties became ill with flu-like symptoms after vacationing abroad and was diagnosed with COVID-19 after returning to Iceland. A few days later he was admitted to the University Hospital, Landspitali, due to worsening respiratory symptoms and severe fatigue. A computed tomography scan of lthe lungs showed diffuse bilateral consolidations and ground glass changes. He developed respiratory failure and was transferred to the intensive care unit where he received further treatment, including tocilizumab (IL-6 receptor inhibitor). He subsequently showed clinical improvement and did not require endotracheal intubation.

Keywords: COVID-19; Coronavirus; Cytokine storm; SARS-CoV-2; Tocilizumab.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / diagnostic imaging
  • Coronavirus Infections / drug therapy*
  • Humans
  • Iceland
  • Lung / diagnostic imaging
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / diagnostic imaging
  • Pneumonia, Viral / drug therapy*
  • SARS-CoV-2
  • Tomography, X-Ray Computed
  • Travel
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab